Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo

Mikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, Darren R. Veach, Peter Smith-Jones, Nagavarakishore Pillarsetty, Julius Balatoni, William Bornmann, Juri Gelovani and Steven M. Larson
Journal of Nuclear Medicine January 2010, 51 (1) 121-129; DOI: https://doi.org/10.2967/jnumed.109.066126
Mikhail Doubrovin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Kochetkova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elmer Santos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darren R. Veach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Smith-Jones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagavarakishore Pillarsetty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julius Balatoni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Bornmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juri Gelovani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven M. Larson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 1 121-129
DOI 
https://doi.org/10.2967/jnumed.109.066126
PubMed 
20048131

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 12, 2007
  • Accepted for publication September 8, 2009
  • Published online January 4, 2010.

Copyright & Usage 
© 2010 by Society of Nuclear Medicine

Author Information

  1. Mikhail Doubrovin * , 1 ,
  2. Tatiana Kochetkova * , 1 ,
  3. Elmer Santos * , 1 ,
  4. Darren R. Veach 1 ,
  5. Peter Smith-Jones 1 ,
  6. Nagavarakishore Pillarsetty 1 ,
  7. Julius Balatoni 1 , 2 ,
  8. William Bornmann 2 ,
  9. Juri Gelovani 2 and
  10. Steven M. Larson 1
  1. 1Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; and 2Department of Experimental Diagnostic Imaging, M.D. Anderson Cancer Center, Houston, Texas
  1. For correspondence or reprints contact: Steven Larson, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., S212C, New York, NY 10021. E-mail: larsons{at}mskcc.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 9 Citations
  • 8 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo
    Greg M. Thurber, Katy S. Yang, Thomas Reiner, Rainer H. Kohler, Peter Sorger, Tim Mitchison, Ralph Weissleder
    Nature Communications 2013 4 1
  • Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls
    Vladimir Tolmachev, Sharon Stone-Elander, Anna Orlova
    The Lancet Oncology 2010 11 10
  • Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
    Justin W. Hicks, Henry F. VanBrocklin, Alan A. Wilson, Sylvain Houle, Neil Vasdev
    Molecules 2010 15 11
  • Effect of Small-Molecule Modification on Single-Cell Pharmacokinetics of PARP Inhibitors
    Greg M. Thurber, Thomas Reiner, Katherine S. Yang, Rainer H. Kohler, Ralph Weissleder
    Molecular Cancer Therapeutics 2014 13 4
  • Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
    Vadim Bernard-Gauthier, Justin Bailey, Sheldon Berke, Ralf Schirrmacher
    Molecules 2015 20 12
  • Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging
    Longguang Tang, Chenyu Peng, Bowen Tang, Zijing Li, Xiangyu Wang, Jindian Li, Fei Gao, Lumei Huang, Duo Xu, Pu Zhang, Rongqiang Zhuang, Xinhui Su, Xiaoyuan Chen, Xianzhong Zhang
    Journal of Nuclear Medicine 2018 59 9
  • Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
    Julie Bolcaen, Shankari Nair, Cathryn Driver, Tebatso Boshomane, Thomas Ebenhan, Charlot Vandevoorde
    Pharmaceuticals 2021 14 7
  • C2c: turning cancer into chronic disease
    Stephan Beck, Tony Ng
    Genome Medicine 2014 6 5

Article usage

Article usage: January 2010 to April 2025

AbstractFullPdf
Jan 20101473896
Feb 2010221837
Mar 2010432017
Apr 201035815
May 201043812
Jun 2010431612
Jul 2010262124
Aug 2010271320
Sep 2010151512
Oct 2010111614
Nov 2010121615
Dec 201091511
Jan 201192217
Feb 2011112116
Mar 201182926
Apr 2011101816
May 201111139
Jun 2011362315
Jul 2011332214
Aug 2011292122
Sep 2011281419
Oct 201132238
Nov 2011331014
Dec 20113488
Jan 201226912
Feb 201231179
Mar 201242913
Apr 201251168
May 201244118
Jun 2012251411
Jul 2012281012
Aug 20123085
Sep 201229149
Oct 2012201415
Nov 201223157
Dec 201221199
Jan 20132577
Feb 2013251210
Mar 2013201611
Apr 201322129
May 2013352510
Jun 201313811
Jul 2013161411
Aug 201338103
Sep 20132288
Oct 2013922
Nov 201319113
Dec 20131805
Jan 201412108
Feb 201417610
Mar 20142376
Apr 20141785
May 20141569
Jun 2014861
Jul 20142078
Aug 2014532
Sep 201424156
Oct 201431136
Nov 20142165
Dec 20148169
Jan 20151654
Feb 201514157
Mar 20153293
Apr 201518140
May 20151881
Jun 20151174
Jul 201510139
Aug 20151891
Sep 201521137
Oct 20151271
Nov 2015954
Dec 201518112
Jan 201637208
Feb 20161961
Mar 20161478
Apr 2016973
May 20161741
Jun 2016141011
Jul 20162076
Aug 20161747
Sep 20161162
Oct 201622115
Nov 20162387
Dec 201616122
Jan 201718196
Feb 20171882
Mar 201714127
Apr 20172050
May 20171040
Jun 20171581
Jul 20171041
Aug 20171283
Sep 2017850
Oct 2017952
Nov 2017931
Dec 20172140
Jan 20181515
Feb 20181160
Mar 20181371
Apr 20181672
May 20181691
Jun 201818120
Jul 201812101
Aug 20181020
Sep 201813116
Oct 2018683
Nov 201818131
Dec 201812151
Jan 201926183
Feb 201930213
Mar 201933223
Apr 201923156
May 20191042
Jun 2019767
Jul 201915123
Aug 20191352
Sep 2019734
Oct 20199304
Nov 20192155
Dec 2019420
Jan 20201083
Feb 2020333
Mar 20201133
Apr 2020422
May 20201453
Jun 20201136
Jul 2020851
Aug 2020443
Sep 2020833
Oct 20201612
Nov 20201014
Dec 2020570
Jan 2021266
Feb 2021398
Mar 20214174
Apr 2021278
May 2021285
Jun 20213104
Jul 2021189
Aug 2021074
Sep 2021073
Oct 20211718
Nov 20210714
Dec 20211196
Jan 20221204
Feb 2022295
Mar 20221156
Apr 2022070
May 2022099
Jun 2022198
Jul 20223217
Aug 20220137
Sep 20220119
Oct 20221513
Nov 20222175
Dec 20221115
Jan 20233194
Feb 2023062
Mar 20231216
Apr 20231142
May 2023182
Jun 2023156
Jul 2023122
Aug 2023156
Sep 2023241
Oct 2023043
Nov 2023183
Dec 20230172
Jan 20240207
Feb 2024176
Mar 20240610
Apr 2024111522
May 202421816
Jun 20242266
Jul 202431914
Aug 20246219
Sep 202431453
Oct 2024498
Nov 2024346
Dec 20241133
Jan 20251154
Feb 20252675
Mar 20252529
Apr 202522415
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (1)
Journal of Nuclear Medicine
Vol. 51, Issue 1
January 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo
Mikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, Darren R. Veach, Peter Smith-Jones, Nagavarakishore Pillarsetty, Julius Balatoni, William Bornmann, Juri Gelovani, Steven M. Larson
Journal of Nuclear Medicine Jan 2010, 51 (1) 121-129; DOI: 10.2967/jnumed.109.066126

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
124I-Iodopyridopyrimidinone for PET of Abl Kinase–Expressing Tumors In Vivo
Mikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, Darren R. Veach, Peter Smith-Jones, Nagavarakishore Pillarsetty, Julius Balatoni, William Bornmann, Juri Gelovani, Steven M. Larson
Journal of Nuclear Medicine Jan 2010, 51 (1) 121-129; DOI: 10.2967/jnumed.109.066126
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging
  • Effect of Small-Molecule Modification on Single-Cell Pharmacokinetics of PARP Inhibitors
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire